Quantitative reverse transcription polymerase chain reaction (RT-qPCR) and Western blotting analysis revealed that IDO1 overexpression increased the mRNA and protein expression levels of SLC7A11, but not GPX4, in GBM cells (Fig. 3C, D). The gene discussed is GPX4; the disease is glioblastoma.